Welcome to our dedicated page for Optimizerx news (Ticker: OPRX), a resource for investors and traders seeking the latest updates and insights on Optimizerx stock.
OptimizeRx Corporation (Nasdaq: OPRX) regularly issues news and updates about its healthcare technology platform, partnerships, and financial performance. Company press releases describe OptimizeRx as a healthcare technology company that helps life science brands reach and engage healthcare professionals (HCPs) and patients through AI-driven tools, point-of-care integrations, and proprietary audience data.
News items for OptimizeRx often cover collaborations with other data and media companies, such as integrations that connect its patented Micro-Neighborhood® audience data with external identity graphs or out-of-home advertising networks. These announcements explain how the company’s privacy-safe, deterministic audience cohorts are used to support omnichannel and direct-to-consumer campaigns, improve audience quality, and reduce audience loss during onboarding and activation.
Investors and observers will also find earnings releases and guidance updates among OptimizeRx news. These releases include discussions of revenue trends, profitability metrics, key performance indicators related to top pharmaceutical manufacturers, and commentary from management about the company’s progress toward its strategic objectives. Conference call announcements and investor conference participation are also common topics, providing details on how to access management’s discussions of quarterly and annual results.
Additional news highlights may include expansions of the company’s in-workflow point-of-care network through new or renewed agreements with electronic health record (EHR) vendors, e-prescribing platforms, and health systems access partners. Leadership updates and organizational changes are reported through current reports and associated press releases, outlining adjustments in executive roles and governance. For anyone following OPRX, this news page serves as a central source for official company communications on partnerships, technology developments, financial results, and corporate governance.
OptimizeRx Corp. (Nasdaq: OPRX) has partnered with Epion Health to enhance patient access to savings programs prior to medical appointments. Patients using Epion’s digital check-in can now connect with OptimizeRx for real-time medication cost-saving opportunities based on their health records. This integration aims to facilitate conversations about affordability between patients and providers, thereby improving treatment outcomes. The partnership is expected to launch next month, expanding services to health systems nationwide, benefiting over 10 million patient appointments annually.
OptimizeRx Corp. (Nasdaq: OPRX), a leader in digital health solutions, is set to participate in two key investor conferences in September. The first event is the H.C. Wainwright’s 22nd Annual Global Investment Conference from September 14-16, featuring 1x1 meetings and a live webcast on September 16 at 1:00 p.m. EDT. The second event is the Lake Street Capital Markets’ 4th Annual Best Ideas Growth Conference on September 17, emphasizing further engagement with institutional investors.
Management will highlight the expansion of its digital health platform and its new FDA-cleared Smart Health Stations, enhancing communication between life science companies, healthcare providers, and patients.
OptimizeRx Corp. (NASDAQ: OPRX) has been invited to present at the LD 500 virtual investor conference from September 1-4, 2020. CEO William Febbo will present on September 3 at 12:20 p.m. Eastern time and will engage in one-on-one meetings with institutional investors. The conference will showcase over 300 micro-cap companies and feature discussions relevant to investors. OptimizeRx aims to highlight its digital health solutions that enhance communication between life science companies, physicians, and patients, particularly with its new network of 10,000 Smart Health Stations.
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its digital health communication network in partnership with Change Healthcare (Nasdaq: CHNG). This collaboration enhances access to vital healthcare information for providers, enabling them to deliver real-time updates on drug savings and treatment options during patient consultations. The integration supports better patient-provider communication, aiming to improve patient outcomes. The Intelligent Healthcare Network™ by Change Healthcare processes 14 billion transactions annually, showcasing a robust platform for data exchange.
OptimizeRx Corp. (Nasdaq: OPRX) will hold a conference call on August 5, 2020, at 4:30 p.m. ET to discuss its Q2 2020 results. The call will be hosted by management, following the release of financial results. Interested participants can dial in using the provided toll-free and international numbers. A replay will be available after the call and can be accessed via the OptimizeRx website. The company specializes in digital health solutions for life sciences and payers, improving communication and patient engagement within healthcare.
OptimizeRx Corp. (Nasdaq: OPRX) has appointed Greg Wasson, former president and CEO of Walgreens Boots Alliance, to its board of directors. This strategic move aims to bolster patient connectivity and enhance digital health services. Wasson, credited for achieving $76.4 billion in sales at Walgreens, brings extensive experience in organizational change and leadership. CEO William Febbo highlighted the growing need for affordability and adherence in digital health, making Wasson's expertise crucial for the company's future growth.
OptimizeRx Corp. (Nasdaq: OPRX) announced securing two new enterprise-level SaaS engagements, one from a new client and another transitioning from a legacy system, averaging an annual contract value of $3.6 million. The company highlights strong revenue potential from converting legacy clients to its enterprise platform, estimating over $100 million in upsell opportunities. CEO William Febbo noted the increasing demand for their digital health solutions amid COVID-19, enhancing communication among pharmaceutical companies, healthcare providers, and patients, thereby improving medication affordability and adherence.
OptimizeRx Corp. (Nasdaq: OPRX) has appointed UHY LLP as its new auditor effective June 22, 2020. This change aims to enhance audit efficiency, particularly by reducing travel costs in light of COVID-19. The company reported two previous weaknesses in internal control, which have not impacted financial results. OptimizeRx has also renewed its membership in the Russell Microcap and 3000 Indexes, signifying growth and visibility in the market. CEO William Febbo noted this growth comes alongside record Q1 results and an increasing customer base with major health systems and pharmaceutical companies.
OptimizeRx Corp. (NASDAQ: OPRX) has expanded its digital communication platform by partnering with over 300 health systems and 75,000 healthcare providers using Epic and Cerner EHRs. This partnership will enhance immediate access to real-time patient savings information, aiming to address medication non-adherence, which costs the healthcare system $528 billion annually. The expansion connects OptimizeRx to an additional 120 million patients, increasing its network reach to over 675,000 prescribers. This growth represents an 11% increase in the largest point-of-prescribe network focused on improving treatment adherence.
OptimizeRx Corp. (Nasdaq: OPRX), a digital health leader, will present at William Blair & Company’s 40th Annual Growth Stock Conference from June 9-11, 2020. CEO William Febbo is set to speak on June 10 at 9:20 a.m. Central time, highlighting the company's record Q1 results and the relevance of its platform during COVID-19. The presentation will be live-streamed for institutional clients.